FHIT alterations in breast cancer

Authors
Citation
S. Ingvarsson, FHIT alterations in breast cancer, SEM CANC B, 11(5), 2001, pp. 361-366
Citations number
52
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
SEMINARS IN CANCER BIOLOGY
ISSN journal
1044579X → ACNP
Volume
11
Issue
5
Year of publication
2001
Pages
361 - 366
Database
ISI
SICI code
1044-579X(200110)11:5<361:FAIBC>2.0.ZU;2-1
Abstract
The FHIT gene encodes a diadenosine hydrolase and may be involved in growth control Pathways of the cell. Studies on protein-protein interactions, cel l lines, including tumourigenicity tests, and knockout mice suggest that th e Fhit protein is involved in cell proliferation and apoptosis, and might a ct as a tumour suppressor In several different cancers, including breast ca ncer, alterations in the FHIT gene have been detected in high frequency. Th e most common alterations are: deletions, DNA hypermethylation, abnormal tr anscripts and reduced expression at RNA and protein le-vel. The FHIT gene i s located at the FRA3B fragile site at chromosome 3p14.2, and alterations i n the FHIT gene and Fhit protein have been found associated with genome ins tability, particularly in BRCA2 mutated breast tumours. This paper will foc us on some of the functional aspects of the Fhit protein with respect to tu mour pathogenesis and on aberrations detected in breast cancer.